Cite

HARVARD Citation

    McCulloch, R. et al. (2021). Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real‐world analysis of outcomes in 211 patients. British journal of haematology. pp. 290-298. [Online]. 
  
Back to record